Guided Therapeutics Stock Fundamentals
| GTHP Stock | USD 0.16 0.03 15.79% |
Guided Therapeutics fundamentals help investors to digest information that contributes to Guided Therapeutics' financial success or failures. It also enables traders to predict the movement of Guided OTC Stock. The fundamental analysis module provides a way to measure Guided Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Guided Therapeutics otc stock.
Guided |
Guided Therapeutics OTC Stock Current Valuation Analysis
Guided Therapeutics' Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Guided Therapeutics Current Valuation | 19.66 M |
Most of Guided Therapeutics' fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Guided Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Guided Therapeutics has a Current Valuation of 19.66 M. This is 99.86% lower than that of the Healthcare sector and 99.84% lower than that of the Medical Devices industry. The current valuation for all United States stocks is 99.88% higher than that of the company.
Guided Therapeutics Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Guided Therapeutics's current stock value. Our valuation model uses many indicators to compare Guided Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Guided Therapeutics competition to find correlations between indicators driving Guided Therapeutics's intrinsic value. More Info.Guided Therapeutics is one of the top stocks in return on asset category among its peers. It also is one of the top stocks in operating margin category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Guided Therapeutics' earnings, one of the primary drivers of an investment's value.Guided Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Guided Therapeutics' direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Guided Therapeutics could also be used in its relative valuation, which is a method of valuing Guided Therapeutics by comparing valuation metrics of similar companies.Guided Therapeutics is currently under evaluation in current valuation category among its peers.
Guided Fundamentals
| Return On Asset | -0.63 | |||
| Operating Margin | (38.63) % | |||
| Current Valuation | 19.66 M | |||
| Shares Outstanding | 48.58 M | |||
| Shares Owned By Insiders | 39.69 % | |||
| Shares Owned By Institutions | 12.65 % | |||
| Price To Earning | 36.67 X | |||
| Price To Sales | 219.47 X | |||
| Revenue | 81 K | |||
| Gross Profit | 20 K | |||
| EBITDA | (837 K) | |||
| Net Income | (2.07 M) | |||
| Cash And Equivalents | 446 K | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 1.43 M | |||
| Debt To Equity | 0.60 % | |||
| Current Ratio | 0.18 X | |||
| Book Value Per Share | (0.13) X | |||
| Cash Flow From Operations | (1.59 M) | |||
| Earnings Per Share | (0.19) X | |||
| Beta | 0.67 | |||
| Market Capitalization | 12.77 M | |||
| Total Asset | 2.04 M | |||
| Retained Earnings | (125.47 M) | |||
| Working Capital | (6.68 M) | |||
| Current Asset | 1.86 M | |||
| Current Liabilities | 8.55 M | |||
| Z Score | -84.2 | |||
| Net Asset | 2.04 M |
About Guided Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Guided Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Guided Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Guided Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Guided Therapeutics, Inc., a medical technology company, focuses on developing medical devices. Guided Therapeutics, Inc. was incorporated in 1992 and is based in Norcross, Georgia. Guided Therapeutics operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 5 people.
Pair Trading with Guided Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Guided Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Guided Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving against Guided OTC Stock
| 0.42 | SMMNY | Siemens Healthineers | PairCorr |
| 0.42 | PHG | Koninklijke Philips | PairCorr |
| 0.39 | SEMHF | Siemens Healthineers | PairCorr |
The ability to find closely correlated positions to Guided Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Guided Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Guided Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Guided Therapeutics to buy it.
The correlation of Guided Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Guided Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Guided Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Guided Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Guided OTC Stock Analysis
When running Guided Therapeutics' price analysis, check to measure Guided Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Guided Therapeutics is operating at the current time. Most of Guided Therapeutics' value examination focuses on studying past and present price action to predict the probability of Guided Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Guided Therapeutics' price. Additionally, you may evaluate how the addition of Guided Therapeutics to your portfolios can decrease your overall portfolio volatility.